Document is current

Article History

Accepted: 12 May 2023

First Online: 6 July 2023

Compliance with Ethical Standards

:

: B.L.M. is a paid consultant/advisor to Abbvie, Pfizer, AVEO oncology, Janssen, Astellas, Bristol-Myers Squibb, Clovis, Tempus, Merck, Exelixis, Bayer Oncology, Lilly, and Peloton Therapeutics; Huntsman Cancer Institute has received research funding from Exelixis (Inst), Bavarian-Nordic (Inst), Clovis (Inst), Genentech (Inst), and Bristol-Myers Squibb (Inst) on his behalf. I have received financial compensation as a paid consultant/advisor to Abbvie, Pfizer, AVEO oncology, Janssen, Astellas, Bristol-Myers Squibb, Clovis, Tempus, Merck, Exelixis, Bayer Oncology, Lilly, and Peloton Therapeutics; Huntsman Cancer Institute has received research funding from Exelixis, Bavarian-Nordic, Clovis, and Bristol-Myers Squibb on my behalf.

: This article does not contain any studies with human or animal subjects performed by any of the authors.